Responses
Late-Breaking Abstracts
Clinical Trial in Progress
1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
